Boesen Biotech ApS: Financial statements 2022
CVR: 39142635
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -36,461 and a net result of DKK -5,462,889 compared with DKK 8,080,859 the year before. Equity in the 2022 report amounted to DKK 4,700,400. The solvency ratio was 42.3%.
- Gross Profit
- DKK -36,461
- Profit/Loss
- DKK -5,462,889
- Equity
- DKK 4,700,400
- Total Assets
- DKK 11,109,093
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -36K | -5.5M | 4.7M | - |
| 2021 | - | -34K | 8.1M | 10.2M | - |
| 2020 | - | -21K | 2.3M | 2.1M | - |
| 2019 | - | -14K | -2K | -227K | - |
| 2018 | - | -20K | -536K | -225K | - |
Official annual report
Keep an eye on Boesen Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Boesen Biotech ApS has published its annual report for 2021. Gross profit came to DKK -33,549, and the net result was DKK 8,080,859.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.